Sponsored by   


Cancer Briefing

Death rates are declining for many common cancers in the U.S., report finds

By Theresa Gaffney

Anne Weston/Francis Crick Institute/Wellcome

Death rates are declining for more than half of the most common forms of cancer in the U.S., according to a new report.

Read More

STAT+: Dozens of generic makers and pharmacies won’t face lawsuits over Zantac and cancer risks

By Ed Silverman

Drew Angerer/Getty Images

A federal court judge explained the lawsuits — which relied to a great extent on state laws — were preempted by federal law.

Read More

STAT+: The failure of a cancer drug study leaves Cel-Sci on the brink of collapse

By Adam Feuerstein

The failure of Cel-Sci’s immunotherapy to prolong survival in head and neck cancer has pushed the biotech to the precipice of insolvency.

Read More

Tuesday, July 13, 2021


Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2021, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us